Jpmorgan Chase & CO Coherus Bio Sciences, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 61,383 shares of CHRS stock, worth $66,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,383

Previous 60,310 1.78%

Holding current value

$66,907

Previous $104,000 39.42%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$0.99 - $1.8 $1,062 - $1,931	1,073 Added 1.78%	61,383 $63,000
Q2 2024 Aug 12, 2024	SELL	$1.58 - $2.51 $263,495 - $418,590	-166,769 Reduced 73.44%	60,310 $104,000
Q1 2024 May 10, 2024	SELL	$2.02 - $3.14 $421,345 - $654,963	-208,587 Reduced 47.88%	227,079 $542,000
Q4 2023 Feb 12, 2024	SELL	$1.59 - $3.85 $7.86 Million - $19 Million	-4,944,542 Reduced 91.9%	435,666 $1.45 Million
Q3 2023 Nov 14, 2023	SELL	$3.74 - $5.45 $1.3 Million - $1.9 Million	-348,710 Reduced 6.09%	5,380,208 $20.1 Million
Q2 2023 Aug 11, 2023	SELL	$3.79 - $8.3 $961,208 - $2.11 Million	-253,617 Reduced 4.24%	5,728,918 $24.5 Million
Q1 2023 May 18, 2023	BUY	$5.89 - $10.52 $518,543 - $926,159	88,038 Added 1.49%	5,982,535 $40.9 Million
Q1 2023 May 11, 2023	SELL	$5.89 - $10.52 $3.6 Million - $6.42 Million	-610,366 Reduced 9.38%	5,894,497 $40.3 Million
Q4 2022 Feb 13, 2023	BUY	$5.69 - $10.07 $2.16 Million - $3.82 Million	379,618 Added 6.2%	6,504,863 $51.5 Million
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $2.59 Million - $5.01 Million	-360,986 Reduced 5.57%	6,125,245 $58.9 Million
Q2 2022 Aug 11, 2022	SELL	$5.86 - $13.23 $523,368 - $1.18 Million	-89,312 Reduced 1.36%	6,486,231 $47 Million
Q1 2022 May 11, 2022	SELL	$10.92 - $16.41 $1.25 Million - $1.87 Million	-114,205 Reduced 1.71%	6,575,543 $84.9 Million
Q4 2021 Feb 10, 2022	SELL	$15.81 - $18.99 $7.61 Million - $9.14 Million	-481,119 Reduced 6.71%	6,689,748 $107 Million
Q3 2021 Nov 12, 2021	BUY	$12.68 - $17.79 $90.9 Million - $128 Million	7,170,867 New	7,170,867 $115 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $84.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Coherus Bio Sciences, Inc. Transaction History